Cardiol Therapeutics Inc. CT9.F Stock
Cardiol Therapeutics Inc. Price Chart
Cardiol Therapeutics Inc. CT9.F Financial and Trading Overview
| Cardiol Therapeutics Inc. stock price | 2.12 EUR |
| Previous Close | 0.76 EUR |
| Open | 0.76 EUR |
| Bid | 0.77 EUR x N/A |
| Ask | 0.79 EUR x N/A |
| Day's Range | 0.76 - 0.76 EUR |
| 52 Week Range | 0.4 - 1.06 EUR |
| Volume | 2.5K EUR |
| Avg. Volume | 690 EUR |
| Market Cap | 49.97M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.32 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CT9.F Valuation Measures
| Enterprise Value | 8.65M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.4048059 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.282 |
Trading Information
Cardiol Therapeutics Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 1.06 EUR |
| 52 Week Low | 0.4 EUR |
| 50-Day Moving Average | 0.79 EUR |
| 200-Day Moving Average | 0.69 EUR |
CT9.F Share Statistics
| Avg. Volume (3 month) | 690 EUR |
| Avg. Daily Volume (10-Days) | 545 EUR |
| Shares Outstanding | 65.11M |
| Float | 61.62M |
| Short Ratio | N/A |
| % Held by Insiders | 4.42% |
| % Held by Institutions | 14.55% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -34.61% |
| Return on Equity (ttm) | -59.87% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -30634032 EUR |
| Net Income Avi to Common (ttm) | -28006292 EUR |
| Diluted EPS (ttm) | -0.29 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 40.54M EUR |
| Total Cash Per Share (mrq) | 0.63 EUR |
| Total Debt (mrq) | 181.21K EUR |
| Total Debt/Equity (mrq) | 0.52 EUR |
| Current Ratio (mrq) | 5.286 |
| Book Value Per Share (mrq) | 0.541 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -28056334 EUR |
| Levered Free Cash Flow (ttm) | -17605260 EUR |
Profile of Cardiol Therapeutics Inc.
| Country | Germany |
| State | ON |
| City | Oakville |
| Address | 2265 Upper Middle Road East |
| ZIP | L6H 0G5 |
| Phone | N/A |
| Website | https://www.cardiolrx.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx for patients hospitalized with COVID-19, as well as for the treatment of recurrent pericarditis and acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Q&A For Cardiol Therapeutics Inc. Stock
What is a current CT9.F stock price?
Cardiol Therapeutics Inc. CT9.F stock price today per share is 2.12 EUR.
How to purchase Cardiol Therapeutics Inc. stock?
You can buy CT9.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cardiol Therapeutics Inc.?
The stock symbol or ticker of Cardiol Therapeutics Inc. is CT9.F.
Which industry does the Cardiol Therapeutics Inc. company belong to?
The Cardiol Therapeutics Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Cardiol Therapeutics Inc. have in circulation?
The max supply of Cardiol Therapeutics Inc. shares is 68.89M.
What is Cardiol Therapeutics Inc. Price to Earnings Ratio (PE Ratio)?
Cardiol Therapeutics Inc. PE Ratio is now.
What was Cardiol Therapeutics Inc. earnings per share over the trailing 12 months (TTM)?
Cardiol Therapeutics Inc. EPS is -0.32 EUR over the trailing 12 months.
Which sector does the Cardiol Therapeutics Inc. company belong to?
The Cardiol Therapeutics Inc. sector is Healthcare.